Biophytis SA (EURONEXT:ALBPS)
European company
Share Price Chart
- Chart currently unavailable -
Market Info - ALBPS
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - ALBPS
- Market Cap€109.720m
- SymbolEURONEXT:ALBPS
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINFR0012816825
Company Profile
Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. The company's drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.Biophytis is a biotechnology company. It is engaged in the treatment of age-related illnesses and develops first-in-class drugs to treat degenerative illnesses associated with aging and treatment to restore muscular & visual functions.
Latest ALBPS news
Currently there for this company. Visit our news hub for other news .